Digoxin non-competitive chemiluminescence immunoassay kit and application thereof
A non-competitive chemiluminescence immunoassay technology, which is applied in the field of non-competitive chemiluminescence immunoassay kits for digoxin, can solve the problems of large zero-dose point error, long reaction incubation time, and difficult to distinguish reaction signals. Achieve the effect of improving detection sensitivity, high accuracy and high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] Example 1 Preparation of digoxin anti-immune complex antibody
[0051] In this example, referring to the method of patent JP2793587, the immune complex formed by digoxin and anti-digoxigenin monoclonal antibody is used as the immunogen to prepare the anti-immune complex antibody, and the steps are as follows:
[0052] Digoxin and mouse anti-digoxigenin monoclonal antibody were preliminarily immunized in vitro, and the immune complex formed by combination was used as an antigen to immunize mice; 15 days, 35 days and 97 days after the initial immunization, booster immunization was carried out. After 3 days of final immunization, hybridomas with the ability to produce anti-monoclonal antibodies were established according to conventional methods;
[0053] Screen the binding capacity of the monoclonal antibodies produced by hybridomas, and select antibodies that are reactive to immune complexes but not to digoxin;
[0054] Purify the screened anti-immune complex antibody wi...
Embodiment 2
[0055] Example 2 Preparation of biotinylated anti-digoxigenin monoclonal antibody
[0056] Dissolve biotin-NHS in DMSO, add anti-digoxigenin monoclonal antibody at a molar ratio of 1:20, mix thoroughly and react at room temperature for 1.8 hours, and obtain biochemical anti-digoxigenin monoclonal antibody after dialysis;
[0057] The biochemical anti-digoxigenin monoclonal antibody was diluted to a working solution of 10 ng / mL with a pH=6.8 buffer containing 25 mM PBS, 0.1% BSA, and 0.1% Proclin300.
Embodiment 3
[0058] Example 3 kit assembly
[0059] Take 1 mL of streptavidin magnetic particles (particle size: 3 μm) with a concentration of 100 mg / mL, add them to 30 mL of buffer solution containing 25 mMPBS and 0.1% Proclin300 at pH=6.8, mix thoroughly and place on a magnetic separator for Magnetic separation, repeat 3 times until the supernatant is free of turbidity, discard the supernatant, and keep the magnetic particles;
[0060] Add magnetic particles to 25mM PBS, 0.1% BSA, 0.1% Proclin300 pH = 6.8 magnetic particle buffer to prepare a magnetic particle working solution with a concentration of 0.1%, which is designated as reagent R1;
[0061] The biotinylated anti-digoxigenin monoclonal antibody working solution prepared in Example 2 is designated as reagent R2;
[0062] The alkaline phosphatase anti-immune complex antibody working solution prepared in Example 1 is designated as reagent R3;
[0063] Reagents R1, R2 and R3 are combined to form a non-competitive chemiluminescence ...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com